Minnesota Legislature
Audio/Video Archives - 2023-2024 Regular Session
Health Finance and Policy
Meetings are listed by date with the most recent meeting at the top. If there is a television recording of the meeting links to that format will be available below.
Health Finance and Policy
3/9/2023
HF2422 (Her): Tobacco use prevention account established, and money appropriated.
HF2041 (Gomez): Service providers authorized to possess, distribute, and dispose of syringes; and possession of hypodermic syringes authorized.
HF1487 (Reyer): Revenue recapture provisions modified, claims from hospitals and ambulance services disallowed.
HF2599 (Reyer): Requirements for hospitals to screen patients for eligibility for health coverage or assistance established, affidavit of expert review required before debt collection activities, and hospital charges limited for uninsured treatments and services for patients.
HF1940 (Bierman): Palliative Care Advisory Council member terms clarified, Palliative Care Advisory Council sunset eliminated, report required, and money appropriated.
HF2160 (Bahner): Commissioner of health fetal alcohol spectrum disorders prevention grant funding provided, and money appropriated.
HF2236 (Hassan): Public awareness campaign on health dangers of using skin-lightening products containing mercury and hydroquinone created.
Bills may be added or removed at the discretion of the Chair.
This hearing has been approved for extra time and will adjourn at 12:30PM
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF2041 (Gomez): Service providers authorized to possess, distribute, and dispose of syringes; and possession of hypodermic syringes authorized.
HF1487 (Reyer): Revenue recapture provisions modified, claims from hospitals and ambulance services disallowed.
HF2599 (Reyer): Requirements for hospitals to screen patients for eligibility for health coverage or assistance established, affidavit of expert review required before debt collection activities, and hospital charges limited for uninsured treatments and services for patients.
HF1940 (Bierman): Palliative Care Advisory Council member terms clarified, Palliative Care Advisory Council sunset eliminated, report required, and money appropriated.
HF2160 (Bahner): Commissioner of health fetal alcohol spectrum disorders prevention grant funding provided, and money appropriated.
HF2236 (Hassan): Public awareness campaign on health dangers of using skin-lightening products containing mercury and hydroquinone created.
Bills may be added or removed at the discretion of the Chair.
This hearing has been approved for extra time and will adjourn at 12:30PM
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF1487
(Reyer) - Revenue recapture provisions modified, claims from hospitals and ambulance services disallowed.
HF1940 (Bierman) - Palliative Care Advisory Council member terms clarified, Palliative Care Advisory Council sunset eliminated, report required, and money appropriated.
HF2422 (Her) - Tobacco use prevention account established, and money appropriated.
HF2599 (Reyer) - Requirements for hospitals to screen patients for eligibility for health coverage or assistance established, affidavit of expert review required before debt collection activities, and hospital charges limited for uninsured treatments and services for patients.
HF2160 (Bahner) - Commissioner of health fetal alcohol spectrum disorders prevention grant funding provided, and money appropriated.
HF2041 (Gomez) - Syringe service providers authorized to possess, distribute, and dispose of syringes; and possession of hypodermic syringes authorized.
HF2236 (Hassan) - Public awareness campaign on health dangers of using skin-lightening products containing mercury and hydroquinone created.
Attachments:
HF1940 (Bierman) - Palliative Care Advisory Council member terms clarified, Palliative Care Advisory Council sunset eliminated, report required, and money appropriated.
HF2422 (Her) - Tobacco use prevention account established, and money appropriated.
HF2599 (Reyer) - Requirements for hospitals to screen patients for eligibility for health coverage or assistance established, affidavit of expert review required before debt collection activities, and hospital charges limited for uninsured treatments and services for patients.
HF2160 (Bahner) - Commissioner of health fetal alcohol spectrum disorders prevention grant funding provided, and money appropriated.
HF2041 (Gomez) - Syringe service providers authorized to possess, distribute, and dispose of syringes; and possession of hypodermic syringes authorized.
HF2236 (Hassan) - Public awareness campaign on health dangers of using skin-lightening products containing mercury and hydroquinone created.
HF1487 HRS.pdf
(3/8/2023)
HF1940 HRS.pdf (3/8/2023)
HF2422 HRS.pdf (3/8/2023)
HF2599 HRS.pdf (3/8/2023)
HF2160 HRS.pdf (3/8/2023)
HF2041 HRS.pdf (3/8/2023)
HF2236 HRS.pdf (3/8/2023)
H2041A1-14850564098586395180.pdf (3/8/2023)
Beautywell Testimony-HF2236.pdf (3/8/2023)
Minnesota-2023-skin lighteners.docx (3/8/2023)
Written Testimoney HF2236-Hafsa Farah.docx (3/8/2023)
Ltr_Sppt_Sanford Health of Northern MN_2023.pdf (3/8/2023)
Legal Aid Ltr of Support - HF 2599.docx (3/8/2023)
Legal Aid Ltr of Support for HF 1487.docx (3/8/2023)
2022 Post Bulletin article on Charity Care.pdf (3/8/2023)
2023 Get Covered Handout.pdf (3/8/2023)
2020 Star Tribune article on Revenue Recapture.pdf (3/8/2023)
2023 Protect Patients Handout.pdf (3/8/2023)
LOS Sanford_Prevention Grant - flat.pdf (3/8/2023)
CDCSSP-FAQ_508.pdf (3/8/2023)
SSP-FactSheet 2.pdf (3/8/2023)
SSP-FAQs.pdf (3/8/2023)
SSP-Summary1.pdf (3/8/2023)
Why we should prevent FASD.pdf (3/8/2023)
3.8.23 AG Letter to Health Finance Committee HF 2422.pdf (3/8/2023)
Funding-Tobacco-Prevention-and-Treatment-Programs.pdf (3/8/2023)
MSFG LOS for HF 2422.pdf (3/8/2023)
Coalition letter re HF1487 3.8.23.pdf (3/8/2023)
2023 MN Palliative Care Bill - One-Pager.pdf (3/8/2023)
2023-03 MN HF 1940 - coalition letter for House Health Finance and Policy hearing.pdf (3/8/2023)
HF2160_Handout_Legislative Priorities_2023.pdf (3/8/2023)
HF2160_Handout_Summary_Our Children Are Sacred_2022.pdf (3/8/2023)
Ltr_Sppt_Avivo Family Treatment Program_2023.docx (3/8/2023)
Ltr_Sppt_Family Service Rochester_2023.pdf (3/8/2023)
Ltr_Sppt_Wayside Recovery Center_2023.pdf (3/8/2023)
Health Finance & Policy Agenda 03.09.23.docx (3/8/2023)
HF2160_Handout_FAQs_FASD (MDH) Grants.docx (3/9/2023)
H2599A2-4517864742939589323.pdf (3/9/2023)
HF1940 HRS.pdf (3/8/2023)
HF2422 HRS.pdf (3/8/2023)
HF2599 HRS.pdf (3/8/2023)
HF2160 HRS.pdf (3/8/2023)
HF2041 HRS.pdf (3/8/2023)
HF2236 HRS.pdf (3/8/2023)
H2041A1-14850564098586395180.pdf (3/8/2023)
Beautywell Testimony-HF2236.pdf (3/8/2023)
Minnesota-2023-skin lighteners.docx (3/8/2023)
Written Testimoney HF2236-Hafsa Farah.docx (3/8/2023)
Ltr_Sppt_Sanford Health of Northern MN_2023.pdf (3/8/2023)
Legal Aid Ltr of Support - HF 2599.docx (3/8/2023)
Legal Aid Ltr of Support for HF 1487.docx (3/8/2023)
2022 Post Bulletin article on Charity Care.pdf (3/8/2023)
2023 Get Covered Handout.pdf (3/8/2023)
2020 Star Tribune article on Revenue Recapture.pdf (3/8/2023)
2023 Protect Patients Handout.pdf (3/8/2023)
LOS Sanford_Prevention Grant - flat.pdf (3/8/2023)
CDCSSP-FAQ_508.pdf (3/8/2023)
SSP-FactSheet 2.pdf (3/8/2023)
SSP-FAQs.pdf (3/8/2023)
SSP-Summary1.pdf (3/8/2023)
Why we should prevent FASD.pdf (3/8/2023)
3.8.23 AG Letter to Health Finance Committee HF 2422.pdf (3/8/2023)
Funding-Tobacco-Prevention-and-Treatment-Programs.pdf (3/8/2023)
MSFG LOS for HF 2422.pdf (3/8/2023)
Coalition letter re HF1487 3.8.23.pdf (3/8/2023)
2023 MN Palliative Care Bill - One-Pager.pdf (3/8/2023)
2023-03 MN HF 1940 - coalition letter for House Health Finance and Policy hearing.pdf (3/8/2023)
HF2160_Handout_Legislative Priorities_2023.pdf (3/8/2023)
HF2160_Handout_Summary_Our Children Are Sacred_2022.pdf (3/8/2023)
Ltr_Sppt_Avivo Family Treatment Program_2023.docx (3/8/2023)
Ltr_Sppt_Family Service Rochester_2023.pdf (3/8/2023)
Ltr_Sppt_Wayside Recovery Center_2023.pdf (3/8/2023)
Health Finance & Policy Agenda 03.09.23.docx (3/8/2023)
HF2160_Handout_FAQs_FASD (MDH) Grants.docx (3/9/2023)
H2599A2-4517864742939589323.pdf (3/9/2023)
Health Finance and Policy
3/8/2023
HF645 (Lee): Disposition of money recovered from litigation or settlement of environmental permit violations provided.
HF742 (Norris): Firefighting foam use prohibited, exemptions allowed, reports required, and money appropriated.
HF1175 (Youakim): Modifying medical assistance coverage for special education school social work services
HF2494 (Coulter): Licensure requirements modified for practice of medicine and acupuncture, and professional corporation rules repealed.
HF1486 (Frederick): Supervised practice of alcohol and drug counseling by former students allowed for limited time etc.
HF1677 (Kraft): Insurance; network adequacy provided, and report required.
Bills may be added or removed at the discretion of the Chair.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF742 (Norris): Firefighting foam use prohibited, exemptions allowed, reports required, and money appropriated.
HF1175 (Youakim): Modifying medical assistance coverage for special education school social work services
HF2494 (Coulter): Licensure requirements modified for practice of medicine and acupuncture, and professional corporation rules repealed.
HF1486 (Frederick): Supervised practice of alcohol and drug counseling by former students allowed for limited time etc.
HF1677 (Kraft): Insurance; network adequacy provided, and report required.
Bills may be added or removed at the discretion of the Chair.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF645
(Lee) - Disposition of money recovered from litigation or settlement of environmental permit violations provided.
HF742 (Norris) - Firefighting foam use prohibited, exemptions allowed, reports required, and money appropriated.
HF1175 (Youakim) - Medical assistance coverage modified for special education school social work services.
HF2494 (Coulter) - Licensure requirements modified for practice of medicine and acupuncture, and professional corporation rules repealed.
HF1486 (Frederick) - Supervised practice of alcohol and drug counseling by former students allowed for limited time, HIV training requirements modified in substance use disorder treatment programs, withdrawal management license requirements modified, and substance use disorder treatment client record documentation requirements modified.
HF1677 (Kraft) - Insurance; network adequacy provided, and report required.
Attachments:
HF742 (Norris) - Firefighting foam use prohibited, exemptions allowed, reports required, and money appropriated.
HF1175 (Youakim) - Medical assistance coverage modified for special education school social work services.
HF2494 (Coulter) - Licensure requirements modified for practice of medicine and acupuncture, and professional corporation rules repealed.
HF1486 (Frederick) - Supervised practice of alcohol and drug counseling by former students allowed for limited time, HIV training requirements modified in substance use disorder treatment programs, withdrawal management license requirements modified, and substance use disorder treatment client record documentation requirements modified.
HF1677 (Kraft) - Insurance; network adequacy provided, and report required.
H0742A6.pdf
(3/6/2023)
H1677A4-4489339946750846116.pdf (3/7/2023)
HF645 HRS.pdf (3/7/2023)
HF742 HRS.pdf (3/7/2023)
HF1175 HRS.pdf (3/7/2023)
HF2494 HRS.pdf (3/7/2023)
HF1486 HRS.pdf (3/7/2023)
HF1677 HRS.pdf (3/7/2023)
Commonly Asked Questions about School Social Workers 2023 (2).pdf (3/7/2023)
Comparison CTSS requirements and IEP-EVAL requirements.docx - Google Docs.pdf (3/7/2023)
Letter for SF 1028 & HF 1175.pdf (3/7/2023)
Written Testimony 1175.pdf (3/7/2023)
Multi-Agency Letter of Support for HF1175.pdf (3/7/2023)
NASW-MN Support Letter for HF1175.docx.pdf (3/7/2023)
HF 1175 Letter of Support - Humphrey Policy Fellows.pdf (3/7/2023)
Support for HF 1175.pdf (3/7/2023)
MNLCOA Supports HF1940.pdf (3/7/2023)
MASE Supprt for HF 1175.pdf (3/7/2023)
Support for HF1175 Written Testimony.pdf (3/7/2023)
HF 1175 Testimony Virnig .docx (3/7/2023)
HF1175.NAMIMN.pdf (3/7/2023)
HFP Minutes 17th 3-2-2023.docx (3/7/2023)
Health Finance & Policy Agenda 03.08.23.docx (3/7/2023)
H1677 A5.pdf (3/8/2023)
Michael Strande (1).docx (3/8/2023)
Jefferey Munter (2).docx (3/8/2023)
Greg Laden (3).docx (3/8/2023)
Donna Bahls (2).docx (3/8/2023)
Derek Lowen (3).docx (3/8/2023)
Ben Rule (4).docx (3/8/2023)
Anna Schlien (4).docx (3/8/2023)
Letter of Support_HF645_City of Mpls_3.7.23.pdf (3/8/2023)
PFAS Sign On Letter.docx (3/8/2023)
2023 PFAS One Pager.pdf (3/8/2023)
PFAS Testimony.docx (3/8/2023)
HF 1175 Youakim Support Letter .pdf (3/8/2023)
H1677A4-4489339946750846116.pdf (3/7/2023)
HF645 HRS.pdf (3/7/2023)
HF742 HRS.pdf (3/7/2023)
HF1175 HRS.pdf (3/7/2023)
HF2494 HRS.pdf (3/7/2023)
HF1486 HRS.pdf (3/7/2023)
HF1677 HRS.pdf (3/7/2023)
Commonly Asked Questions about School Social Workers 2023 (2).pdf (3/7/2023)
Comparison CTSS requirements and IEP-EVAL requirements.docx - Google Docs.pdf (3/7/2023)
Letter for SF 1028 & HF 1175.pdf (3/7/2023)
Written Testimony 1175.pdf (3/7/2023)
Multi-Agency Letter of Support for HF1175.pdf (3/7/2023)
NASW-MN Support Letter for HF1175.docx.pdf (3/7/2023)
HF 1175 Letter of Support - Humphrey Policy Fellows.pdf (3/7/2023)
Support for HF 1175.pdf (3/7/2023)
MNLCOA Supports HF1940.pdf (3/7/2023)
MASE Supprt for HF 1175.pdf (3/7/2023)
Support for HF1175 Written Testimony.pdf (3/7/2023)
HF 1175 Testimony Virnig .docx (3/7/2023)
HF1175.NAMIMN.pdf (3/7/2023)
HFP Minutes 17th 3-2-2023.docx (3/7/2023)
Health Finance & Policy Agenda 03.08.23.docx (3/7/2023)
H1677 A5.pdf (3/8/2023)
Michael Strande (1).docx (3/8/2023)
Jefferey Munter (2).docx (3/8/2023)
Greg Laden (3).docx (3/8/2023)
Donna Bahls (2).docx (3/8/2023)
Derek Lowen (3).docx (3/8/2023)
Ben Rule (4).docx (3/8/2023)
Anna Schlien (4).docx (3/8/2023)
Letter of Support_HF645_City of Mpls_3.7.23.pdf (3/8/2023)
PFAS Sign On Letter.docx (3/8/2023)
2023 PFAS One Pager.pdf (3/8/2023)
PFAS Testimony.docx (3/8/2023)
HF 1175 Youakim Support Letter .pdf (3/8/2023)
Health Finance and Policy
3/7/2023
HF2286 (Noor): Commissioner of human services procedures established related to transition from public health emergency, continuous medical assistance eligibility provided for children, state-funded cost-sharing reduction program established, and money appropriated.
HF17 (Stephenson): Excessive price increases by manufacturers to generic or off-patent drugs prohibited.
HF2621 (Schomacker): Health care capital expenditure notification and reporting changed.
HF2275 (Reyer): Definition added for medical assistance room and board rate, eligible grant fund uses modified etc.
HF2050 (Liebling): Vital record provisions changed for stillbirths.
This bill will function as a vehicle in the assembly of a Minnesota Department of Health policy omnibus. The bill will be amended by adding provisions previously laid over for omnibus inclusion.
HF1790 (Liebling): Health insurance; preexisting condition limitations prohibited in Medicare supplement insurance policies, and Medicare supplement benefits governing provisions modified and added.
Bills may be added or removed at the discretion of the Chair.
This hearing has been approved for extra time and will adjourn at 12:30PM
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF17 (Stephenson): Excessive price increases by manufacturers to generic or off-patent drugs prohibited.
HF2621 (Schomacker): Health care capital expenditure notification and reporting changed.
HF2275 (Reyer): Definition added for medical assistance room and board rate, eligible grant fund uses modified etc.
HF2050 (Liebling): Vital record provisions changed for stillbirths.
This bill will function as a vehicle in the assembly of a Minnesota Department of Health policy omnibus. The bill will be amended by adding provisions previously laid over for omnibus inclusion.
HF1790 (Liebling): Health insurance; preexisting condition limitations prohibited in Medicare supplement insurance policies, and Medicare supplement benefits governing provisions modified and added.
Bills may be added or removed at the discretion of the Chair.
This hearing has been approved for extra time and will adjourn at 12:30PM
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF17
(Stephenson) - Generic or off-patent drugs; Excessive price increases prohibited, attorney general authorized to take action against price increases, sale withdrawal prohibited, prescription drug affordability board and advisory council established, prescription drug cost reviews and remedies provided, and money appropriated.
HF2050 (Liebling) - Health policy bill.
HF2286 (Noor) - Commissioner of human services procedures established related to the transition from the public health emergency, and money appropriated.
HF1790 (Liebling) - Health insurance; preexisting condition limitations prohibited in Medicare supplement insurance policies, and Medicare supplement benefits governing provisions modified and added.
HF2275 (Reyer) - Definition added for medical assistance room and board rate, eligible grant fund uses modified, cultural and ethnic minority infrastructure grant program created, mental health grant programs created, transition from homelessness program created, housing supports program created for adults with serious mental illness, definition of supportive housing modified, and application requirements modified.
HF2621 (Schomacker) - Health care capital expenditure notification and reporting changed.
Attachments:
HF2050 (Liebling) - Health policy bill.
HF2286 (Noor) - Commissioner of human services procedures established related to the transition from the public health emergency, and money appropriated.
HF1790 (Liebling) - Health insurance; preexisting condition limitations prohibited in Medicare supplement insurance policies, and Medicare supplement benefits governing provisions modified and added.
HF2275 (Reyer) - Definition added for medical assistance room and board rate, eligible grant fund uses modified, cultural and ethnic minority infrastructure grant program created, mental health grant programs created, transition from homelessness program created, housing supports program created for adults with serious mental illness, definition of supportive housing modified, and application requirements modified.
HF2621 (Schomacker) - Health care capital expenditure notification and reporting changed.
HF2286 HRS.pdf
(3/2/2023)
HF2050 HRS.pdf (3/2/2023)
HF17.3 HRS.pdf (3/2/2023)
H0017A9-5630324244973556471.pdf (3/3/2023)
HF17-2A Completed FN.pdf (3/3/2023)
H2286A2-14194451611745181854.pdf (3/3/2023)
HF 17.pdf (3/6/2023)
MN HF17 PDAB Statement 3.3.23.pdf (3/6/2023)
MNO Drug Affordability Board HF17 House Health and Finace letter.pdf (3/6/2023)
More Than Half of Every Dollar Spent on Medicines Goes to Someone Who Doesnt Make Them 4ALT[99].pdf (3/6/2023)
new overviewphrma-prnt-onepager-policiestopayless-v8[15][66][58].pdf (3/6/2023)
Summary_IQVIA 2022_Use of Medicine[65][47].pdf (3/6/2023)
Supply Chain Slide[44].pdf (3/6/2023)
Linda Larson Support Letter HF17 3.7.23.pdf (3/6/2023)
MFU Support for PDAB (HF17) 3.7.23.pdf (3/6/2023)
PDAB_MNGroupLetter_House Health Finance 3-7-23.pdf (3/6/2023)
HF 17 Health Finance and Policy - Oppose.pdf (3/6/2023)
Patient Stories.pdf (3/6/2023)
PDAB & Rx Price Gouging One Pager.pdf (3/6/2023)
PDAB_MNGroupLetter_House Health Finance 3-7-23.pdf (3/6/2023)
MCHP PHE_2023.03.07.pdf (3/6/2023)
PN3_Support HF2286_Health F & P_03.07.23 (1).pdf (3/6/2023)
HealthPlansCouncil_HF2286.pdf (3/6/2023)
HF2286 Unwind - Authors A2 2023.03.06 2.30PM.pdf (3/6/2023)
H1790A1-1026480497699646945.pdf (3/6/2023)
MN_Oppose HF 17.pdf (3/6/2023)
BIO HF 17 Statement Opposition HHS.pdf (3/6/2023)
CAE Comments on HF17 (3-6-2023).pdf (3/6/2023)
This Is Medicaid Letter of Support HF2286.docx (3/6/2023)
Continuous-Eligibility-One-pager.pdf (3/6/2023)
HFP Minutes 16th 3-1-2023.docx (3/6/2023)
Minnesota HF 17_NASHP Testimony House Health Finance and Policy.pdf (3/6/2023)
HF2621 HRS.pdf (3/6/2023)
HF2275 HRS.pdf (3/6/2023)
HF1790 HRS.pdf (3/6/2023)
H0017A10-8956500358348365626.pdf (3/6/2023)
H0017A11-15967827402497415414.pdf (3/6/2023)
H0017A12-11528948579684509870.pdf (3/6/2023)
H2050A2-5503706173890176269.pdf (3/6/2023)
H2050A3-7989599795771467758.pdf (3/6/2023)
H2050DE1-69824969643781556.pdf (3/6/2023)
Minnesota HF 17_NASHP Testimony House Health Finance and Policy.pdf (3/6/2023)
HF2050 HRS.pdf (3/2/2023)
HF17.3 HRS.pdf (3/2/2023)
H0017A9-5630324244973556471.pdf (3/3/2023)
HF17-2A Completed FN.pdf (3/3/2023)
H2286A2-14194451611745181854.pdf (3/3/2023)
HF 17.pdf (3/6/2023)
MN HF17 PDAB Statement 3.3.23.pdf (3/6/2023)
MNO Drug Affordability Board HF17 House Health and Finace letter.pdf (3/6/2023)
More Than Half of Every Dollar Spent on Medicines Goes to Someone Who Doesnt Make Them 4ALT[99].pdf (3/6/2023)
new overviewphrma-prnt-onepager-policiestopayless-v8[15][66][58].pdf (3/6/2023)
Summary_IQVIA 2022_Use of Medicine[65][47].pdf (3/6/2023)
Supply Chain Slide[44].pdf (3/6/2023)
Linda Larson Support Letter HF17 3.7.23.pdf (3/6/2023)
MFU Support for PDAB (HF17) 3.7.23.pdf (3/6/2023)
PDAB_MNGroupLetter_House Health Finance 3-7-23.pdf (3/6/2023)
HF 17 Health Finance and Policy - Oppose.pdf (3/6/2023)
Patient Stories.pdf (3/6/2023)
PDAB & Rx Price Gouging One Pager.pdf (3/6/2023)
PDAB_MNGroupLetter_House Health Finance 3-7-23.pdf (3/6/2023)
MCHP PHE_2023.03.07.pdf (3/6/2023)
PN3_Support HF2286_Health F & P_03.07.23 (1).pdf (3/6/2023)
HealthPlansCouncil_HF2286.pdf (3/6/2023)
HF2286 Unwind - Authors A2 2023.03.06 2.30PM.pdf (3/6/2023)
H1790A1-1026480497699646945.pdf (3/6/2023)
MN_Oppose HF 17.pdf (3/6/2023)
BIO HF 17 Statement Opposition HHS.pdf (3/6/2023)
CAE Comments on HF17 (3-6-2023).pdf (3/6/2023)
This Is Medicaid Letter of Support HF2286.docx (3/6/2023)
Continuous-Eligibility-One-pager.pdf (3/6/2023)
HFP Minutes 16th 3-1-2023.docx (3/6/2023)
Minnesota HF 17_NASHP Testimony House Health Finance and Policy.pdf (3/6/2023)
HF2621 HRS.pdf (3/6/2023)
HF2275 HRS.pdf (3/6/2023)
HF1790 HRS.pdf (3/6/2023)
H0017A10-8956500358348365626.pdf (3/6/2023)
H0017A11-15967827402497415414.pdf (3/6/2023)
H0017A12-11528948579684509870.pdf (3/6/2023)
H2050A2-5503706173890176269.pdf (3/6/2023)
H2050A3-7989599795771467758.pdf (3/6/2023)
H2050DE1-69824969643781556.pdf (3/6/2023)
Minnesota HF 17_NASHP Testimony House Health Finance and Policy.pdf (3/6/2023)
Health Finance and Policy
3/2/2023
HF348 (Howard): Cost-sharing limited for prescription drugs and related medical supplies to treat chronic disease.
HF544 (Freiberg): PBM and health carrier requirements related to clinician-administered drugs.
HF1752 (Liebling): Commissioner of human services directed to establish a prescription drug purchasing program, program authority and eligibility requirements specified, and report required.
HF1665 (Bierman): Minnesota's schedules of controlled substances modified. (This bill was heard informationally in committee on February 14, 2023)
HF1711 (Elkins): Pharmacy benefit managers and health carriers required to use prescription drug rebates and other compensation to benefit covered persons, and report required.
This hearing has been approved for extra time and will adjourn at 12:30PM
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF544 (Freiberg): PBM and health carrier requirements related to clinician-administered drugs.
HF1752 (Liebling): Commissioner of human services directed to establish a prescription drug purchasing program, program authority and eligibility requirements specified, and report required.
HF1665 (Bierman): Minnesota's schedules of controlled substances modified. (This bill was heard informationally in committee on February 14, 2023)
HF1711 (Elkins): Pharmacy benefit managers and health carriers required to use prescription drug rebates and other compensation to benefit covered persons, and report required.
This hearing has been approved for extra time and will adjourn at 12:30PM
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF348
(Howard) - Cost-sharing limited for prescription drugs and related medical supplies to treat chronic disease.
HF544 (Freiberg) - Pharmacy benefit manager and health carrier requirements established related to clinician-administered drugs.
HF1711 (Elkins) - Pharmacy benefit managers and health carriers required to use prescription drug rebates and other compensation to benefit covered persons, and report required.
HF1752 (Liebling) - Commissioner of human services directed to establish a prescription drug purchasing program, program authority and eligibility requirements specified, and report required.
HF1665 (Bierman) - Minnesota's schedules of controlled substances modified.
Attachments:
HF544 (Freiberg) - Pharmacy benefit manager and health carrier requirements established related to clinician-administered drugs.
HF1711 (Elkins) - Pharmacy benefit managers and health carriers required to use prescription drug rebates and other compensation to benefit covered persons, and report required.
HF1752 (Liebling) - Commissioner of human services directed to establish a prescription drug purchasing program, program authority and eligibility requirements specified, and report required.
HF1665 (Bierman) - Minnesota's schedules of controlled substances modified.
H0544A1-2916583236907087149.pdf
(3/1/2023)
HF2286 HRS.pdf (3/1/2023)
HF1752 HRS.pdf (3/1/2023)
HF544 HRS.pdf (3/1/2023)
HF348 HRS.pdf (3/1/2023)
HF1711 HRS.pdf (3/1/2023)
1752de1 Liebling.rc.pdf (3/1/2023)
H1752DE1-3272215740877938186.pdf (3/1/2023)
H2286A2-14194451611745181854.pdf (3/1/2023)
H0348A2-1627151210050241561.pdf (3/1/2023)
HF1665 HRS.pdf (3/1/2023)
2023 NMSS HF 17 Support Letter FINAL Health Finance.pdf (3/1/2023)
2023.03.02 NFIB Ltr re SF482-HF544 (Pharmacy Networks).pdf (3/1/2023)
Cigna Concerns HF544.pdf (3/1/2023)
Copay Cap Testimony.pdf (3/1/2023)
Document3.pdf (3/1/2023)
HDA MN HF 544 White Bagging Letter.pdf (3/1/2023)
HealthPlansCouncil_HF2286.pdf (3/1/2023)
HF 348 ADA Support.pdf (3/1/2023)
Legislative funding request letter - Health Finance and Policy .docx (3/1/2023)
MACHP - Letter re HF1752-SF2067 FINAL 3-1-23.pdf (3/1/2023)
Madame Chair Rep Tina Liebling.docx (3/1/2023)
MFU HF1752 Support Letter 3.2.23.pdf (3/1/2023)
MHA HF 1752 340B Issue Brief_3.2.2023.pdf (3/1/2023)
MHA HF 1752 340B Issue Letter_3.2.2023.pdf (3/1/2023)
Minnesota Medicaid One-Pager_21 (2).pdf (3/1/2023)
MN Chamber - HF 348 3.2.23.pdf (3/1/2023)
MN HF 348 _ PCMA Testimony _ Health Finance and Policy Committee - FINAL.pdf (3/1/2023)
MN HF 544 White Bagging Legislation Cost Analysis.pdf (3/1/2023)
MN HF 544 White-Bagging Letter .pdf (3/1/2023)
MSCO_ASCO_HF 544_Support.pdf (3/1/2023)
Navigator Coalition Advocacy One Pager.pdf (3/1/2023)
new overviewphrma-prnt-onepager-policiestopayless-v8[15][66].pdf (3/1/2023)
PhRMA Statement MN HF 1711 Prescription Drug Rebate Pass Through.pdf (3/1/2023)
PhRMA Statement MN HF 1752 Prescription Drug Purchasing Program Statement.pdf (3/1/2023)
PPL_OnePager_ShareTheSavings_051122.pdf (3/1/2023)
Share the Savings Inforgraphic_2021 .6%[77].pdf (3/1/2023)
Summary_IQVIA 2022_Use of Medicine[65].pdf (3/1/2023)
Testimony .pdf (3/1/2023)
Testimony Slides (1).pdf (3/1/2023)
White Bagging One Pager PF.pdf (3/1/2023)
Youland HF1752 Testimony.docx (3/1/2023)
H0544A2-1-14646762184699872148.pdf (3/2/2023)
H0544A3-8263913291862663321.pdf (3/2/2023)
Health Finance & Policy Agenda 03.02.23.docx (3/2/2023)
Adam Pavek Testimony - HF1752_3-2-23.pdf (3/2/2023)
HF2286 HRS.pdf (3/1/2023)
HF1752 HRS.pdf (3/1/2023)
HF544 HRS.pdf (3/1/2023)
HF348 HRS.pdf (3/1/2023)
HF1711 HRS.pdf (3/1/2023)
1752de1 Liebling.rc.pdf (3/1/2023)
H1752DE1-3272215740877938186.pdf (3/1/2023)
H2286A2-14194451611745181854.pdf (3/1/2023)
H0348A2-1627151210050241561.pdf (3/1/2023)
HF1665 HRS.pdf (3/1/2023)
2023 NMSS HF 17 Support Letter FINAL Health Finance.pdf (3/1/2023)
2023.03.02 NFIB Ltr re SF482-HF544 (Pharmacy Networks).pdf (3/1/2023)
Cigna Concerns HF544.pdf (3/1/2023)
Copay Cap Testimony.pdf (3/1/2023)
Document3.pdf (3/1/2023)
HDA MN HF 544 White Bagging Letter.pdf (3/1/2023)
HealthPlansCouncil_HF2286.pdf (3/1/2023)
HF 348 ADA Support.pdf (3/1/2023)
Legislative funding request letter - Health Finance and Policy .docx (3/1/2023)
MACHP - Letter re HF1752-SF2067 FINAL 3-1-23.pdf (3/1/2023)
Madame Chair Rep Tina Liebling.docx (3/1/2023)
MFU HF1752 Support Letter 3.2.23.pdf (3/1/2023)
MHA HF 1752 340B Issue Brief_3.2.2023.pdf (3/1/2023)
MHA HF 1752 340B Issue Letter_3.2.2023.pdf (3/1/2023)
Minnesota Medicaid One-Pager_21 (2).pdf (3/1/2023)
MN Chamber - HF 348 3.2.23.pdf (3/1/2023)
MN HF 348 _ PCMA Testimony _ Health Finance and Policy Committee - FINAL.pdf (3/1/2023)
MN HF 544 White Bagging Legislation Cost Analysis.pdf (3/1/2023)
MN HF 544 White-Bagging Letter .pdf (3/1/2023)
MSCO_ASCO_HF 544_Support.pdf (3/1/2023)
Navigator Coalition Advocacy One Pager.pdf (3/1/2023)
new overviewphrma-prnt-onepager-policiestopayless-v8[15][66].pdf (3/1/2023)
PhRMA Statement MN HF 1711 Prescription Drug Rebate Pass Through.pdf (3/1/2023)
PhRMA Statement MN HF 1752 Prescription Drug Purchasing Program Statement.pdf (3/1/2023)
PPL_OnePager_ShareTheSavings_051122.pdf (3/1/2023)
Share the Savings Inforgraphic_2021 .6%[77].pdf (3/1/2023)
Summary_IQVIA 2022_Use of Medicine[65].pdf (3/1/2023)
Testimony .pdf (3/1/2023)
Testimony Slides (1).pdf (3/1/2023)
White Bagging One Pager PF.pdf (3/1/2023)
Youland HF1752 Testimony.docx (3/1/2023)
H0544A2-1-14646762184699872148.pdf (3/2/2023)
H0544A3-8263913291862663321.pdf (3/2/2023)
Health Finance & Policy Agenda 03.02.23.docx (3/2/2023)
Adam Pavek Testimony - HF1752_3-2-23.pdf (3/2/2023)
Health Finance and Policy
3/1/2023
Department of Health Policy Bills
HF1465 (Koegel): Administration of opiate antagonists for drug overdose provision changed.
HF1329 (Carroll): Cancer reporting provisions changed.
HF1356 (Jordan): Definitions for regulation of safe drinking water added.
HF1447 (Jordan): Renovation and lead hazard reduction provisions modified.
HF1491 (Quam): Rural health advisory committee membership expanded.
HF1679 (Hemmingsen-Jaeger): Hospital physical environment provisions modified.
HF2038 (Hemmingsen-Jaeger): Federal compliance for over-the-counter hearing aid provisions changed.
HF2050 (Liebling): Vital record provisions changed for stillbirths.
HF2052 (Liebling): Home care survey aligned with assisted living licensure survey.
HF2231 (Perryman): Nursing home change of ownership updated.
HF2232 (Perryman): Nursing home moratorium process changed.
Bills may be added or removed at the behest of the Chair.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF1465 (Koegel): Administration of opiate antagonists for drug overdose provision changed.
HF1329 (Carroll): Cancer reporting provisions changed.
HF1356 (Jordan): Definitions for regulation of safe drinking water added.
HF1447 (Jordan): Renovation and lead hazard reduction provisions modified.
HF1491 (Quam): Rural health advisory committee membership expanded.
HF1679 (Hemmingsen-Jaeger): Hospital physical environment provisions modified.
HF2038 (Hemmingsen-Jaeger): Federal compliance for over-the-counter hearing aid provisions changed.
HF2050 (Liebling): Vital record provisions changed for stillbirths.
HF2052 (Liebling): Home care survey aligned with assisted living licensure survey.
HF2231 (Perryman): Nursing home change of ownership updated.
HF2232 (Perryman): Nursing home moratorium process changed.
Bills may be added or removed at the behest of the Chair.
Remote or virtual testimony is not available.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF1329
(Carroll) - Cancer reporting provisions changed.
HF1356 (Jordan) - Definitions for regulation of safe drinking water added.
HF1447 (Jordan) - Renovation and lead hazard reduction provisions modified.
HF1465 (Koegel) - Administration of opiate antagonists for drug overdose provision changed.
HF1491 (Quam) - Rural health advisory committee membership expanded.
HF1679 (Hemmingsen-Jaeger) - Hospital physical environment provisions modified.
HF2038 (Hemmingsen-Jaeger) - Federal compliance for over-the-counter hearing aid provisions changed.
HF2050 (Liebling) - Health policy bill.
HF2052 (Liebling) - Home care survey aligned with assisted living licensure survey.
HF2231 (Perryman) - Nursing home change of ownership updated.
HF2232 (Perryman) - Nursing home moratorium process changed.
Attachments:
HF1356 (Jordan) - Definitions for regulation of safe drinking water added.
HF1447 (Jordan) - Renovation and lead hazard reduction provisions modified.
HF1465 (Koegel) - Administration of opiate antagonists for drug overdose provision changed.
HF1491 (Quam) - Rural health advisory committee membership expanded.
HF1679 (Hemmingsen-Jaeger) - Hospital physical environment provisions modified.
HF2038 (Hemmingsen-Jaeger) - Federal compliance for over-the-counter hearing aid provisions changed.
HF2050 (Liebling) - Health policy bill.
HF2052 (Liebling) - Home care survey aligned with assisted living licensure survey.
HF2231 (Perryman) - Nursing home change of ownership updated.
HF2232 (Perryman) - Nursing home moratorium process changed.
H2050A1-3073319987746927544.pdf
(2/27/2023)
H1679A1-1368862469347682373.pdf (2/27/2023)
H2052A2-1-1790573506672679718.pdf (2/28/2023)
H2038A1-6791179179511758455.pdf (2/28/2023)
H1465A1-13574133105941805292.pdf (2/28/2023)
H1329A1-16989766293590198889.pdf (2/28/2023)
H1356A1-2937540528277657424.pdf (2/28/2023)
H1447A1-17509322696594156568.pdf (2/28/2023)
Housing First Comments HF 1447 (Jordan).pdf (2/28/2023)
LOS Cancer Registry 2023.pdf (2/28/2023)
MCC Letter to MN Leg re HF1329rev.pdf (2/28/2023)
MNNPCR_Compliance Letter_2023.pdf (2/28/2023)
HF 1329 Letter of Support.pdf (2/28/2023)
Health Finance & Policy Agenda 03.01.23.docx (2/28/2023)
HF1329 HRS.pdf (3/1/2023)
HF1356 HRS.pdf (3/1/2023)
HF1447 HRS.pdf (3/1/2023)
HF1465 HRS.pdf (3/1/2023)
HF1491 HRS.pdf (3/1/2023)
HF1679 HRS.pdf (3/1/2023)
HF2038 HRS.pdf (3/1/2023)
HF2050 HRS.pdf (3/1/2023)
H1679A1-1368862469347682373.pdf (2/27/2023)
H2052A2-1-1790573506672679718.pdf (2/28/2023)
H2038A1-6791179179511758455.pdf (2/28/2023)
H1465A1-13574133105941805292.pdf (2/28/2023)
H1329A1-16989766293590198889.pdf (2/28/2023)
H1356A1-2937540528277657424.pdf (2/28/2023)
H1447A1-17509322696594156568.pdf (2/28/2023)
Housing First Comments HF 1447 (Jordan).pdf (2/28/2023)
LOS Cancer Registry 2023.pdf (2/28/2023)
MCC Letter to MN Leg re HF1329rev.pdf (2/28/2023)
MNNPCR_Compliance Letter_2023.pdf (2/28/2023)
HF 1329 Letter of Support.pdf (2/28/2023)
Health Finance & Policy Agenda 03.01.23.docx (2/28/2023)
HF1329 HRS.pdf (3/1/2023)
HF1356 HRS.pdf (3/1/2023)
HF1447 HRS.pdf (3/1/2023)
HF1465 HRS.pdf (3/1/2023)
HF1491 HRS.pdf (3/1/2023)
HF1679 HRS.pdf (3/1/2023)
HF2038 HRS.pdf (3/1/2023)
HF2050 HRS.pdf (3/1/2023)
Select Criteria
Choose a session year below - all committee audio recordings for that year will be listed in the results column.
Choose a committee below - this list is based on the chosen session year and will filter results to that specific committee.
Minnesota House of Representatives · 100 Rev. Dr. Martin Luther King Jr. Blvd. Saint Paul, MN 55155 · Webmaster@house.mn